ArticleCurrent microbiology2025
Modification of Starch-Ammonium Sulfate Concentration To Enhance the Antibacterial Activity of Marine Streptomyces Aureofaciens A3.
Article in Current microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study is the first to report an enhancement in the antibacterial activity of Streptomyces aureofaciens A3 when cultured in an artificial seawater-based ISP4A medium. The primary objective was to evaluate both the antibacterial activity and metabolite profile of S. aureofaciens A3 cultured in ISP4A medium with varying concentrations of starch and ammonium sulfate, designated as C1, C2, C3, N1, N2, and N3. The activated inoculum (10%, v/v) was fermented for 14 days at 28 °C with agitation at 150 rpm, then extracted with methanol to obtain a methanol extract. The antibacterial activity of the extract was tested using the Kirby-Bauer method. The results showed that the methanol extract from the N2 medium produced the largest inhibition zones, with diameters of 20.80 mm against E. coli and 11.41 mm against B. subtilis. Furthermore, the methanol extracts from both N2 and C1 media exhibited the highest inhibition zones against S. aureus (18.90 mm) and P. aeruginosa (14.80 mm). GC/MS analysis of these extracts identified several major compounds, including hexadecanoic acid, methyl stearate, pyrrolo[1,2-a] pyrazine-1,4-dione, bis(2-ethylhexyl) phthalate, and benzene-propanoic acid. These findings suggest that an optimal concentration of starch and ammonium sulfate enhances the broad-spectrum antibacterial activity of S. aureofaciens A3.
Indexed as
Identifiers
41217468What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.